@FierceMedDev: Siemens snagged FDA clearance for a new MRI scanner the company says is more cost-effective than its competitors. Release | Follow @FierceMedDev
@MarkHFierce: A new study connects increased heart attack risk with total hip and knee replacement surgery. More | Follow @MarkHFierce
@DamianFierce: The FDA has slapped CareFusion with another Class I recall over leaky ventilators. Story | Follow @DamianFierce
> Universal Hospital Services, which manages and services medical equipment for the healthcare industry, is proposing a $425 million private offering. Release
> Researchers at the University of Michigan report that cell-specific targeting with cardiac ablation devices could reduce the need for repeat procedures in patients with cardiac arrhythmia. Release
> The Health Information Trust Alliance is launching its Cyber Threat Analysis Service, compiling intelligence to protect medical records and devices from cyber attacks and hacking. News
> Life Technologies ($LIFE) is teaming up with the Southern African Treatment and Resistance Network to provide low-cost HIV diagnostics in that country. More
> Illumina ($ILMN) is launching NuPCR, a new real-time diagnostic reagent for customized multiplex assays. Item
> Ariosa Diagnostics completed its first clinical study for Harmony, a pre-natal test designed to detect common fetal trisomies. Ariosa is currently being sued by Sequenom, which claims Harmony violates its patent on a similar test. Story
> Codman Neurovascular, which is part of Johnson & Johnson ($JNJ), is launching two new microcoil systems in the United States and Europe. Release
> Oakworks, a designer and maker of medical positioning equipment, treatment tables and accessories, has named former Aramark executive Richard Shuman as its new chief financial officer. Release
Biotech News
@FierceBiotech: A handful of genetic mutations drive acute leukemia transformation. Article | Follow @FierceBiotech
@JohnCFierce: Washout. Via NYT: Bapi investigator says "absolutely no evidence at all of a clinical benefit". Report | Follow @JohnCFierce
@RyanMFierce: Hard to find who in bio isn't using Big Data. Special Report: 10 Reasons Why Biotech Needs Big Data. Report | Follow @RyanMFierce
> Merck snags Chimerix antiviral HIV program in $168.5M deal. News
> Pfizer, J&J report ominous PhIII failure of bapineuzumab in Alzheimer's study. Article
> Forest outpaces major league rivals in race for a COPD drug approval. Story
> Sarepta extension study delivers promising results for DMD patients. Item
Pharma News
@FiercePharma: Acorda's MS drug Ampyra gets FDA warning on seizure risks. More | Follow @FiercePharma
> Tang Capital can't shuttle Savient into receivership, judge says. Article
> Italian drug cuts threaten thousands of jobs, industry says. Story
> FDA staff backs Roche's Lucentis for new use. News
Pharma Manufacturing News
> Owens & Minor buys unit from wholesaler Celesio. More
> Strides Arcolab to expand manufacturing in Africa with French investment. Report
> Drugmakers played unintended role in counterfeits hitting U.S. Article
> New Florida drugmaker springs from debacle of another. Story
> NZ doc faces 30 years after fake Cialis conviction. News
Biotech Research News
> Novel class of Alzheimer's drugs looks promising in animals. Story
> A handful of genetic mutations drive acute leukemia transformation. Article
> One molecule may stand in the way of liver cancer. Report
> Genetic mutations linked to childhood brain cancer subtypes. More
And Finally... Analysts project the "sleep industry" could be worth $32.4 billion this year, including drugs, therapy and a burgeoning field of devices designed to help patients get a good night's rest. Article